SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around its anti-establishment narrative, viewing it as a movement against traditional retirement systems. Buoyed by a strong and active community, the coin's mission is to challenge the status quo. Discussions revolve around its potential for significant growth and staking opportunities.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is trending due to anticipation surrounding its upcoming "AirLock" launch, designed to incentivize holding through community-owned supply control and rewards. The community is actively discussing the potential for AirLock to revive a strong holding culture and its impact on the token's value. Bullish sentiment is also fueled by the project's active community engagement and consistent updates.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" crypto ($CAW) is trending due to community enthusiasm and meme-driven engagement, with many calling for it to reach a 1 billion market cap. Integrations across multiple chains, including Solana, Ethereum, and Cronos, are a key focus, as is its deflationary burn mechanism. A collaborative 'meme war' with $PMV is also fueling interest.

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

eXoZymes Inc.

eXoZymes ($EXOZ) is trending due to its advancements in cell-free biomanufacturing, particularly the 100-fold scale-up of NCT production with impressive efficiency. The community is focused on the potential of NCT in the nutraceutical and pharmaceutical markets, especially its role alongside GLP-1 drugs and in addressing liver health. Discussions also highlight the company's AI-driven approach and partnerships, positioning eXoZymes as a leader in sustainable biomanufacturing.

Alchemy Pay

ACH is trending with community members discussing its potential and expressing frustration over its price action. Some point to upcoming catalysts like new partnerships and the potential launch of Alchemy Chain. Others speculate on buyout or merger possibilities, while many are focused on short-term price movements and potential gains.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

ABBV is trending due to a mix of factors, including analyst upgrades and discussions around its pipeline and potential acquisitions. The community is weighing the impact of trial terminations and assessing its resilience amidst sector rotation, with some highlighting its defensive qualities and steady cash flow. Bullish sentiment is fueled by strong performance in immunology, particularly Skyrizi and Rinvoq, and expectations for continued growth.

Sui is an innovative layer-1 blockchain platform crafted to meet the demands of global adoption, providing a secure, robust, and scalable development environment. Rooted in a unique object-centric data model and fortified by the trusted Move programming language, Sui is engineered to tackle the inefficiencies found in current blockchain frameworks.  In addition to its solid technical underpinnings, Sui places a strong emphasis on user experience, aiming to remove common barriers encountered in blockchain interactions. Through groundbreaking features such as zkLogin, sponsored transactions, and programmable transaction blocks, Sui sets a new standard for user accessibility and friendliness within Web3 applications.  Unique elements of Sui Sui’s innovative architecture ensures swift transactions with stable fees and high throughput through horizontal scaling. Its object-oriented design offers deep composability for developers, enabling tailored object types with network-wide compatibility. This revolutionizes asset and protocol collaboration, fostering product innovation.  The platform's object-oriented approach dramatically improves transaction processing, enabling parallel execution and faster completion times. Additionally, unique consensus requirements expedite transaction finalization while maintaining stability. Sui prioritizes overcoming Web3 adoption barriers, offering native tools like zkLogin and sponsored transactions for wallet onboarding and fee management.  Move integration into Sui's data model combines innovation with security, mitigating common exploits found in smart contract languages. This empowers developers and users with a secure and intuitive platform, accelerating the evolution of Web3 applications.  About the Sui token The SUI token serves four primary functions within the Sui ecosystem: Proof-of-stake participation - Sui implements a delegated proof-of-stake mechanism, rewarding honest behavior by validators and SUI token holders who stake with them. Gas fee payments - SUI tokens cover gas fees for executing transactions and storing data onchain. Application utility - SUI is a versatile asset, integral to various applications within Sui’s ecosystem, including decentralized exchanges, lending platforms, gaming, and more. Governance - The SUI token empowers holders to participate in on-chain voting on significant matters like protocol upgrades and platform changes, shaping the future of Sui.  Additionally, the Sui storage fund ensures fair compensation for validators by distributing stake rewards over time and covering storage costs for previously stored on-chain data. This tokenomic strategy promotes indefinite data storage while maintaining fair compensation for validators, fostering long-term sustainability.

SUI is trending as the community discusses its potential for institutional adoption and its underlying technology, including the Move language. Comparisons are being drawn to other Layer 1 solutions like Keeta, with community members debating the merits of each. Catalysts mentioned include potential ETF approvals and increased transaction volume.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

$XRPI is trending as traders discuss its potential as an ETF alternative for gaining exposure to XRP, with some highlighting its tax advantages within certain investment accounts. Community members are actively debating its correlation to XRP's price movements and speculating on future price targets. The broader conversation includes discussion around Ripple's partnerships and potential impact on the global payment system.

CryingNTheCasino

$TEARY is gaining traction with its 'No Crying In The Casino' narrative, fostering a strong community that emphasizes conviction and long-term holding, particularly within the $SOL ecosystem. Community members highlight the project's focus on community building and resilience during market dips. The project is drawing comparisons to other Solana tokens, with holders expressing optimism for future growth.

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Ligand Pharmaceuticals ($LGND) is trending due to recent analyst target price raises and positive ratings, highlighting an improved growth outlook. Community discussion points to potential pipeline valuation debates and upcoming catalysts, including key PDUFA dates and trial data releases. The stock's royalty-based business model and diversified biopharma strategy are also attracting attention.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4D Advisors LLC Makes New $2.06 Million Investment in Bio-Techne Corp $TECH

4D Advisors LLC acquired a new stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 40,000...

Osterweis Capital Management Inc. Has $7.70 Million Stake in Bio-Techne Corp $TECH

Osterweis Capital Management Inc. lowered its position in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 43.9% during the second quarter, according to its most recent Form 13F filing with the SEC...

Cerity Partners LLC Boosts Stake in Bio-Techne Corp $TECH

Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) by 20.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D...

Bio-Techne Corp $TECH Stake Lessened by SVB Wealth LLC

SVB Wealth LLC decreased its position in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) by 54.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Brokerages

Bio-Techne Corp (NASDAQ:TECH - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seventeen research firms that are covering the firm, MarketBeat Ratings reports...

Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and...

WINTON GROUP Ltd Makes New $6.23 Million Investment in Bio-Techne Corp $TECH

WINTON GROUP Ltd acquired a new stake in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange...

Bio-Techne Corp $TECH Shares Sold by Invesco Ltd.

Invesco Ltd. cut its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 12.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange...

Arrowstreet Capital Limited Partnership Has $18.94 Million Stake in Bio-Techne Corp $TECH

Arrowstreet Capital Limited Partnership lifted its position in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) by 551.9% in the 2nd quarter, according to the company in its most recent Form 13F...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Current Price	$58.51
Prev Close	$60.26
Open	$60.57
Dividend Yield	0.62%
50-Day Moving Average	$61.29
Beta	1.14
Avg. Volume	2.11M
PE Ratio	119.60

52-Week High	$79.28
52-Week Low	$46.01
Market Capitalization	$9.12B
EPS (Annual)	$0.4593
Price to Book	4.64
Revenue Per Employee	$393,430.65
Enterprise Value/EBITDA	N/A

TECH
Bio-Techne Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TECH News

TECHBio-Techne Corp